LABCORP HOLDINGS INC (LH) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:LH - US5049221055 - Common Stock
LH Key Statistics, Chart & Performance
The current stock price of LH is 250.88 USD. In the past month the price decreased by -5.66%. In the past year, price increased by 9.48%.
LH Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.59 | 100.74B | ||
| CI | THE CIGNA GROUP | 9.69 | 73.52B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 123.74 | 22.76B | ||
| DGX | QUEST DIAGNOSTICS INC | 17.78 | 19.30B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.16B | ||
| DVA | DAVITA INC | 12.31 | 8.02B | ||
| HIMS | HIMS & HERS HEALTH INC | 60.13 | 7.39B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 36.72 | 6.75B | ||
| CHE | CHEMED CORP | 19.45 | 6.06B | ||
| RDNT | RADNET INC | 187.76 | 5.50B | ||
| OPCH | OPTION CARE HEALTH INC | 21.38 | 5.06B | ||
| WGS | GENEDX HOLDINGS CORP | 69.18 | 3.76B |
Related stock screener links
About LH
Company Profile
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development, medical device and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
Company Info
LABCORP HOLDINGS INC
358 S Main St
Burlington NORTH CAROLINA 27215 US
CEO: Adam H. Schechter
Employees: 70000
Phone: 13362291127
LABCORP HOLDINGS INC / LH FAQ
What does LABCORP HOLDINGS INC do?
Labcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company is headquartered in Burlington, North Carolina and currently employs 70,000 full-time employees. The firm operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The BLS segment provides drug development, medical device and CDx development solutions from early-stage research to clinical development, along with support for crop protection and chemical testing, through its ED and Central Laboratory Services businesses. Its service also includes ambulatory outpatient laboratory services. The firm is focused on four primary specialty testing areas, such as oncology, women's health, autoimmune disease, and neurology.
What is the current price of LH stock?
The current stock price of LH is 250.88 USD. The price decreased by -0.87% in the last trading session.
Does LH stock pay dividends?
LABCORP HOLDINGS INC (LH) has a dividend yield of 1.13%. The yearly dividend amount is currently 2.91.
What is the ChartMill rating of LABCORP HOLDINGS INC stock?
LH has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What sector and industry does LABCORP HOLDINGS INC belong to?
LABCORP HOLDINGS INC (LH) operates in the Health Care sector and the Health Care Providers & Services industry.
Is LABCORP HOLDINGS INC (LH) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on LH.
What is the outstanding short interest for LABCORP HOLDINGS INC?
The outstanding short interest for LABCORP HOLDINGS INC (LH) is 3.82% of its float.
LH Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to LH. When comparing the yearly performance of all stocks, LH turns out to be only a medium performer in the overall market: it outperformed 43.52% of all stocks.
LH Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to LH. LH has only an average score on both its financial health and profitability.
LH Financial Highlights
Over the last trailing twelve months LH reported a non-GAAP Earnings per Share(EPS) of 15.82. The EPS increased by 9.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.21% | ||
| ROA | 4.68% | ||
| ROE | 9.83% | ||
| Debt/Equity | 0.59 |
LH Forecast & Estimates
29 analysts have analysed LH and the average price target is 305.75 USD. This implies a price increase of 21.87% is expected in the next year compared to the current price of 250.88.
For the next year, analysts expect an EPS growth of 15.41% and a revenue growth 7.76% for LH